Peer-reviewed veterinary case report
Cytokine changes before and after treatment in young dogs
By Singh, Alok et al.·Published in Veterinary parasitology·2019·Department of Veterinary Medicine, India·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Pre- and post-therapy circulating immuno-stimulatory and immuno-suppressive cytokines in dogs with juvenile-onset generalized demodecosis.
- Species:
- dog
Plain-English summary
A group of nine dogs with juvenile-onset generalized demodecosis, a skin condition caused by an overgrowth of Demodex mites, were treated with amitraz rinse to help reduce the mite population. After 60 days of treatment, the dogs showed a significant decrease in a specific immune marker (IL-10), which suggests that the treatment was effective in reducing the mites and improving the dogs' immune response. However, other immune markers did not show significant changes. Overall, the treatment helped manage the condition, leading to healthier skin and reduced mite levels.
People also search for: dog skin problems Demodex mites · juvenile-onset generalized demodecosis treatment · amitraz rinse for dogs
Abstract
Overproliferation of Demodex mites in dogs with compromised immunity attributed to the development of canine demodecosis. Whether clinical signs of canine demodecosis are triggered by genetically-mediated specific immunodeficiency in dogs or the Demodex mites induce lesions in hair follicles and result in compromised immunity is yet to be fully explored. To unravel the concealments of immunosuppression in canine demodecosis the present study was aimed to estimate the levels of circulating cytokines, pre- and post-therapy in nine dogs with juvenile-onset generalized demodecosis. At day 60 post-therapy of recommended amitraz rinse, significant (p ≤ 0.02) reduction in circulating IL-10 level was observed compared to its level before the start of the therapy (day 0). However, significant alterations in circulating levels of TNF-α and IFN-γ were not observed in these dogs at day 60 post-therapy as compared to their day 0 levels. A strong positive correlation between circulating level of IL-10 and mites population was observed both on day 0 (r = 0.656; p ≤ 0.005) and day 60 post-therapy (r = 0.575; p ≤ 0.018). Therefore, our findings suggest that Demodex mites induce immunosuppression in dogs during clinical disease and mites burden seems to be responsible for the development of generalized demodecosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31634689/